共 50 条
- [41] Changes in Sensitization and Habituation Measured by Algometry in Chronic Migraine Patients Treated with Onabotulinumtoxin A JOURNAL OF HEADACHE AND PAIN, 2022, 23 (SUPPL 1):
- [42] Fremanezumab plus plasmapheresis in a patient with chronic migraine and myasthenia gravis: Case report of an effective treatment HEADACHE, 2023, 63 (04): : 565 - 568
- [44] Onabotulinumtoxin A for Chronic Migraine with Medication Overuse: Preliminary Clinical Results and Changes in Catastrophising JOURNAL OF HEADACHE AND PAIN, 2018, 19
- [45] Sustained response to onabotulinumtoxin A in patients with chronic migraine: real-life data The Journal of Headache and Pain, 2020, 21
- [47] Sustained response to onabotulinumtoxin A in patients with chronic migraine: real-life data JOURNAL OF HEADACHE AND PAIN, 2020, 21 (01):
- [48] EHMTI-0283. Predictors of early response to onabotulinumtoxin type a in chronic migraine The Journal of Headache and Pain, 2014, 15
- [50] Case Report: Chronic Migraine successfully treated with Cannabinoids JOURNAL OF HEADACHE AND PAIN, 2018, 19